UnitedHealth Group (NYSE:UNH) Hits New 1-Year High – Should You Buy?

UnitedHealth Group Incorporated (NYSE:UNH) hit a new 52-week high on Wednesday . The stock traded as high as $430.77 and last traded at $427.0280, with a volume of 750905 shares traded. The stock had previously closed at $428.19.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Royal Bank of Canada raised its price target on UnitedHealth Group to $463 from $400 and kept an outperform rating, reinforcing a bullish view on the stock’s upside. Benzinga
• Positive Sentiment: UnitedHealth’s healthcare leadership helped drive a broader rally in the sector, with commentary pointing to strong managed care and health insurance momentum across the group. Kalkine Media
• Positive Sentiment: StockTwits highlighted UNH among stocks hitting 52-week highs, citing earnings optimism and healthcare strength as key drivers. StockTwits
• Positive Sentiment: UnitedHealthcare launched a new Lifestyle Spending Account benefit, adding another consumer-focused product that could support growth in employer-sponsored offerings. Yahoo Finance
• Positive Sentiment: A report on UnitedHealth’s Home Health program said HouseCall was associated with fewer inpatient stays and ER visits, suggesting its care model may improve outcomes and lower costs. Home Health Care News
• Neutral Sentiment: Several articles noted UnitedHealth is nearing a quarterly earnings report, keeping investor focus on execution and forward guidance rather than any single headline. American Banking News
• Neutral Sentiment: Broader healthcare-sector strength and ETF inflows are supporting sentiment, but this is more of a backdrop than a UNH-specific catalyst. ETF Trends
• Negative Sentiment: Some commentary warned investors not to chase UNH too aggressively, arguing that the company may not be the best healthcare pick despite industry growth. The Motley Fool
• Negative Sentiment: The New York Times reported that UnitedHealth is among insurers suing states over laws targeting pharmacy businesses, highlighting ongoing regulatory and legal pressure on the industry. New York Times

Analyst Upgrades and Downgrades

UNH has been the topic of several analyst reports. Jefferies Financial Group boosted their target price on UnitedHealth Group from $340.00 to $373.00 and gave the company a “buy” rating in a research report on Monday, April 20th. Royal Bank Of Canada boosted their price objective on shares of UnitedHealth Group from $400.00 to $463.00 and gave the company an “outperform” rating in a research report on Thursday. Argus raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price target for the company in a research note on Wednesday, April 22nd. Cantor Fitzgerald reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, June 11th. Finally, Morgan Stanley upped their target price on UnitedHealth Group from $453.00 to $468.00 and gave the company an “overweight” rating in a research note on Tuesday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $417.38.

UnitedHealth Group Trading Up 1.2%

The stock’s 50-day moving average price is $398.30 and its 200 day moving average price is $338.28. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80. The firm has a market capitalization of $391.30 billion, a PE ratio of 32.54, a price-to-earnings-growth ratio of 1.71 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The company had revenue of $111.65 billion for the quarter, compared to analysts’ expectations of $109.84 billion. During the same quarter in the prior year, the firm earned $7.20 earnings per share. UnitedHealth Group’s revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 18.32 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were given a dividend of $2.32 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date of this dividend was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. UnitedHealth Group’s payout ratio is 70.09%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer owned 17,805 shares in the company, valued at $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.28% of the company’s stock.

Institutional Trading of UnitedHealth Group

Several hedge funds have recently modified their holdings of the company. Brighton Jones LLC raised its stake in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC lifted its holdings in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the last quarter. CMT Capital Markets Trading GmbH purchased a new position in UnitedHealth Group during the 2nd quarter worth $340,000. Flow Traders U.S. LLC acquired a new stake in UnitedHealth Group in the second quarter worth about $356,000. Finally, Jump Financial LLC acquired a new position in shares of UnitedHealth Group during the second quarter valued at about $377,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.